Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| endothelial cell | 18 studies | 29% ± 13% | |
| astrocyte | 15 studies | 35% ± 17% | |
| oligodendrocyte precursor cell | 12 studies | 39% ± 18% | |
| fibroblast | 11 studies | 25% ± 10% | |
| oligodendrocyte | 11 studies | 33% ± 11% | |
| GABAergic neuron | 10 studies | 45% ± 24% | |
| glutamatergic neuron | 10 studies | 51% ± 24% | |
| microglial cell | 10 studies | 27% ± 9% | |
| adipocyte | 9 studies | 28% ± 7% | |
| ciliated cell | 7 studies | 28% ± 9% | |
| smooth muscle cell | 7 studies | 25% ± 7% | |
| neuron | 6 studies | 37% ± 17% | |
| interneuron | 6 studies | 57% ± 23% | |
| macrophage | 6 studies | 29% ± 9% | |
| pericyte | 6 studies | 30% ± 13% | |
| retinal cone cell | 6 studies | 21% ± 3% | |
| T cell | 6 studies | 21% ± 4% | |
| endothelial cell of lymphatic vessel | 6 studies | 27% ± 8% | |
| epithelial cell | 5 studies | 41% ± 12% | |
| amacrine cell | 5 studies | 30% ± 9% | |
| club cell | 5 studies | 23% ± 8% | |
| type I pneumocyte | 5 studies | 25% ± 7% | |
| type II pneumocyte | 5 studies | 26% ± 8% | |
| granule cell | 4 studies | 39% ± 9% | |
| B cell | 4 studies | 22% ± 6% | |
| retinal bipolar neuron | 4 studies | 25% ± 7% | |
| cardiac muscle cell | 4 studies | 27% ± 2% | |
| lymphocyte | 4 studies | 30% ± 9% | |
| myeloid cell | 4 studies | 20% ± 3% | |
| Mueller cell | 4 studies | 21% ± 3% | |
| retina horizontal cell | 4 studies | 26% ± 1% | |
| retinal rod cell | 4 studies | 24% ± 5% | |
| dendritic cell | 4 studies | 21% ± 5% | |
| monocyte | 4 studies | 25% ± 2% | |
| basal cell | 4 studies | 32% ± 17% | |
| mast cell | 4 studies | 19% ± 4% | |
| GABAergic interneuron | 3 studies | 43% ± 4% | |
| CD4-positive, alpha-beta T cell | 3 studies | 19% ± 3% | |
| GABAergic amacrine cell | 3 studies | 31% ± 6% | |
| glycinergic amacrine cell | 3 studies | 30% ± 4% | |
| retinal ganglion cell | 3 studies | 20% ± 3% | |
| rod bipolar cell | 3 studies | 30% ± 7% | |
| endothelial cell of vascular tree | 3 studies | 25% ± 13% | |
| hepatocyte | 3 studies | 35% ± 16% | |
| retinal pigment epithelial cell | 3 studies | 35% ± 20% | |
| alveolar macrophage | 3 studies | 27% ± 6% | |
| goblet cell | 3 studies | 35% ± 20% | |
| transit amplifying cell | 3 studies | 38% ± 26% | |
| mural cell | 3 studies | 28% ± 11% | |
| mucus secreting cell | 3 studies | 25% ± 1% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 3501.41 | 1445 / 1445 | 100% | 41.42 | 183 / 183 |
| ovary | 100% | 5011.82 | 180 / 180 | 100% | 51.72 | 430 / 430 |
| breast | 100% | 3153.79 | 459 / 459 | 99% | 43.28 | 1112 / 1118 |
| prostate | 100% | 3299.59 | 245 / 245 | 99% | 27.33 | 499 / 502 |
| thymus | 100% | 3573.70 | 653 / 653 | 99% | 39.00 | 601 / 605 |
| brain | 100% | 2909.37 | 2631 / 2642 | 100% | 28.22 | 703 / 705 |
| intestine | 100% | 3606.45 | 966 / 966 | 99% | 24.33 | 523 / 527 |
| lung | 100% | 2548.97 | 576 / 578 | 100% | 30.70 | 1150 / 1155 |
| uterus | 100% | 4504.90 | 170 / 170 | 99% | 26.48 | 455 / 459 |
| stomach | 100% | 2484.14 | 359 / 359 | 99% | 30.85 | 283 / 286 |
| skin | 100% | 3499.43 | 1809 / 1809 | 99% | 30.41 | 467 / 472 |
| bladder | 100% | 3996.52 | 21 / 21 | 99% | 21.86 | 497 / 504 |
| pancreas | 100% | 1953.09 | 327 / 328 | 99% | 21.74 | 176 / 178 |
| kidney | 100% | 2550.34 | 89 / 89 | 96% | 26.49 | 865 / 901 |
| adrenal gland | 100% | 3294.98 | 258 / 258 | 95% | 20.59 | 218 / 230 |
| liver | 100% | 1422.72 | 226 / 226 | 90% | 16.75 | 366 / 406 |
| adipose | 100% | 2968.84 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 3814.51 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 100% | 22.44 | 80 / 80 |
| muscle | 100% | 3726.31 | 803 / 803 | 0% | 0 | 0 / 0 |
| spleen | 100% | 2672.39 | 241 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 10.26 | 1 / 1 |
| heart | 98% | 1974.58 | 842 / 861 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 98% | 27.63 | 44 / 45 |
| lymph node | 0% | 0 | 0 / 0 | 90% | 16.74 | 26 / 29 |
| peripheral blood | 83% | 1451.18 | 772 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0031124 | Biological process | mRNA 3'-end processing |
| GO_0097550 | Cellular component | transcription preinitiation complex |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0000993 | Molecular function | RNA polymerase II complex binding |
| GO_0099122 | Molecular function | RNA polymerase II C-terminal domain binding |
| Gene name | RPRD2 |
| Protein name | Regulation of nuclear pre-mRNA domain-containing protein 2 |
| Synonyms | KIAA0460 HSPC099 |
| Description | |
| Accessions | Q5VT52 ENST00000401000.8 [Q5VT52-3] ENST00000369068.5 [Q5VT52-1] ENST00000369067.7 [Q5VT52-4] |